7
May
2024

CritiTech Particle Engineering Solutions

Exhibitor at CPHI North America 2024 stand 1306
About Us

CritiTech Particle Engineering Solutions is a multi-service CDMO that supports clients from POC through GMP. We offer drug development and manufacturing services using spray drying and our proprietary PurcisionTM Technology, a particle engineering technology that is especially useful for formulating and manufacturing drugs for local, targeted delivery. Our analytical and method development services are extensive and not only support our particle engineering and manufacturing clients but other clients as well. We can handle cytotoxic and potent materials, each in separate, dedicate...

  • US
  • 2023
    On CPHI since
  • 1
    Certificates
  • 25 - 49
    Employees
Company types
CMO/CDMO
Primary activities
Analytical Services
Contract Manufacturer
Contact info
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 1306

Products Featured at CPHI North America 2024

  • Analytical Services & Methods

    Product Analytical Services & Methods

    CritiTech provides a suite of material characterization and analytical services to support our clients drug development projects from proof-of-concept through cGMP production. Our testing data and documentation is reviewed by experienced technical and quality staff to ensure it can be used to support regul...
  • Purcision™ - Platform for Direct to Target Drugs

    Product Purcision™ - Platform for Direct to Target Drugs

    Purcision™ is a proven particle engineering technology used to develop new drugs and reformulate and repurpose existing drugs for multiple delivery systems.
    • Purcision technology is different from other particle engineering technologies (CESS, RESS, spray drying, milling)
    • Purcision technology ...
  • Spray Drying - GMP, Cyto or Non-Cyto, Potent

    Product Spray Drying - GMP, Cyto or Non-Cyto, Potent

    CritiTech's range of Spray Drying services is what sets it apart from other CDMOs. From Proof of Concept through GMP scale production. Dedicated Cytotoxic and Non-Cytotoxic SD equipment and facilities. Ability to process potent materials. Other key features include:
    • Spray-dried dispersions - API + p...